![EndoPredict Test](https://microsmallcap.com/wp-content/uploads/2017/12/Myriad-Genetics-Seeing-Positive-Results-from-EndoPredict-Test-Data-374x295.png)
Biotechnology
Myriad Genetics Seeing Positive Results from EndoPredict Test Data
Myriad Genetics, Inc. (NASDAQ:MYGN) has made several developments in its EndoPredict studies. The company now has data that shows that the EndoPredict tests are able to predict residual cancer burden in certain cancer patients. The ... [Read]
![](https://microsmallcap.com/wp-content/uploads/2017/12/Iovance-Biotherapeutics-Webcasting-its-Analyst-Day-on-December-13-374x295.jpg)
Biotechnology
Iovance Biotherapeutics Webcasting its Analyst Day on December 13
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) will be webcasting its Analyst Day on Wednesday, December 13 from 9:00 am to 12:00 pm EST. The event, being held in New York City, will highlight Iovance’s lead clinical programs. ... [Read]
![Spectrum Pharmaceuticals](https://microsmallcap.com/wp-content/uploads/2017/12/Stock-Update-for-Spectrum-Pharmaceuticals-374x295.jpg)
Biotechnology
Stock Update for Spectrum Pharmaceuticals
Based on the most recent trading session, shares for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) closed at $18.63, with a change of -3.12%. 677,566 shares traded hands. Spectrum’s stock currently has an average trading capacity of 1.87 ... [Read]
![Spectrum Pharmaceuticals, Inc.](https://microsmallcap.com/wp-content/uploads/2017/11/Spectrum-Doubles-in-Three-Months-Heres-Why-374x295.jpg)
Biotechnology
Spectrum Pharmaceuticals, Inc. Doubles in Three Months – Here’s Why
Shares for Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) have more than doubled in the past three months. With a 110% increase, they are well beyond the comparable 5.3% rise of its corresponding industry. So where has this ... [Read]
![Iovance Biotherapeutics Inc.](https://microsmallcap.com/wp-content/uploads/2017/11/A-Closer-Look-at-Iovance-Biotherapeutics-Inc.s-Recent-Trading-Lows-374x295.jpg)
Biotechnology
A Closer Look at Iovance Biotherapeutics Inc.’s Recent Trading Lows
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) recently had a low trading volume day. The volume for the company on November 13th was recorded to 0.39 million contracts. Over the past three months, the average daily trading volume ... [Read]
![Spectrum Pharmaceuticals](https://microsmallcap.com/wp-content/uploads/2017/11/Spectrum-Pharmaceuticals-Announces-Phase-2-Trial-of-Poziotinib-374x295.jpg)
Biotechnology
Spectrum Pharmaceuticals Announces Phase 2 Trial of Poziotinib
Last week, Spectrum Pharmaceuticals, Inc. (NASDAQ:$SSPI), announced the initiation of a Phase 2 trial of poziotinib in non-small cell lung cancer patients with Exon 20 insertion mutation in EGFR or HER2. The biotechnology company runs ... [Read]
![](https://microsmallcap.com/wp-content/uploads/2017/10/Zacks-Investment-Research-Upgrades-VBI-Vaccines-Inc.-to-Hold-1-374x295.jpg)
Biotechnology
Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’
A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]
![Spectrum Phamarceuticals](https://microsmallcap.com/wp-content/uploads/2017/10/Spectrum-Pharmaceuticals-Inc.-Sees-Price-Target-Raised-by-Jefferies-Group-LLC-374x295.jpg)
Biotechnology
Spectrum Pharmaceuticals Inc. Sees Price Target Raised by Jefferies Group LLC
In a research note from Monday, Jefferies Group LLC (NYSE:$JEF) raised its target price for Spectrum Pharmaceuticals Inc. (NASDAQ:$SPPI) stock from $13.00 to $18.00. This would indicate a potential upside of 26.05% from the company’s ... [Read]
![Spectrum Pharmaceuticals](https://microsmallcap.com/wp-content/uploads/2017/10/Jefferies-Group-Issues-Forecast-for-Spectrum-Pharmaceuticals-for-Q3-2017-374x263.png)
Biotechnology
Jefferies Group Issues Forecast for Spectrum Pharmaceuticals for Q3 2017
On Monday, Jefferies Group analysts listed their Q3 forecasts for Spectrum Pharmaceuticals Inc. (NASDAQ:$SPPI) stock. Analyst M. Andrews says the stock will likely increase from the prior quarter’s -$0.18 EPS and reach an EPS of -$0.16. ... [Read]
![VBI Vaccines](https://microsmallcap.com/wp-content/uploads/2017/10/Zacks-Investment-Research-Upgrades-VBI-Vaccines-Inc.-to-Hold-374x295.jpg)
Biotechnology
Zacks Investment Research Upgrades VBI Vaccines’ Rating
In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]